mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-05 |